Daniel R Engel Selected Research

Daniel R Engel Research Topics

4	Infections 01/2020 - 01/2013
3	Proteinuria 04/2012 - 03/2008
2	Hemolytic-Uremic Syndrome 01/2021 - 01/2018
2	Kidney Diseases (Kidney Disease) 01/2021 - 10/2015
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2013
2	Pyelonephritis 10/2013 - 02/2012
2	Nephritis 02/2011 - 03/2008
1	Neoplasms (Cancer) 10/2022
1	Adenocarcinoma 10/2022
1	Cerebral Malaria 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2018
1	Peritonitis 05/2015
1	Inflammation (Inflammations) 01/2014
1	Macular Degeneration (Age-Related Maculopathy) 01/2014
1	Choroidal Neovascularization 01/2014
1	Blindness (Hysterical Blindness) 01/2014
1	Glomerulonephritis 10/2013
1	Ileus 12/2010
1	Eye Diseases (Eye Disease) 08/2008

4	AntigensIBA 10/2022 - 03/2008
4	CytokinesIBA 01/2014 - 03/2008
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2013
3	ChemokinesIBA 10/2013 - 02/2012
2	Shiga Toxin (Shigella Toxin)IBA 01/2021 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 02/2011 - 03/2008
2	Interleukin-12 (IL 12)IBA 02/2011 - 12/2010
1	ProgranulinsIBA 10/2022
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2021
1	ProteomeIBA 01/2020
1	Fc Receptors (Fc Receptor)IBA 05/2015
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2015
1	Chemokine ReceptorsIBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Cytokine Receptor gp130IBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Doxycycline (Periostat)FDA LinkGeneric 04/2012
1	Fingolimod Hydrochloride (FTY720)FDA Link 12/2010
1	Pharmaceutical PreparationsIBA 12/2010
1	Transcription Factors (Transcription Factor)IBA 12/2010
1	CreatinineIBA 03/2008
1	Diphtheria ToxinIBA 03/2008

2	Therapeutics 01/2021 - 12/2010
2	Lasers (Laser) 01/2014 - 08/2008
1	Investigational Therapies (Experimental Therapy) 01/2019
1	Kidney Transplantation 10/2015